HIV drug resistance in low-income and middle-income countries
Author:
Publisher
Elsevier BV
Subject
Virology,Infectious Diseases,Immunology,Epidemiology
Reference64 articles.
1. The WHO public health approach to HIV treatment and care: looking back and looking ahead;Ford;Lancet Infect Dis,2018
2. HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis;Gupta;Lancet Infect Dis,2018
3. Impact of HIV drug resistance on HIV/AIDS-associated mortality, new infections, and antiretroviral therapy program costs in sub–Saharan Africa;Phillips;J Infect Dis,2017
4. Risk factors and mortality associated with resistance to first-line antiretroviral therapy: multicentric cross-sectional and longitudinal analyses;Pinoges;J Acquir Immune Defic Syndr,2015
5. Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study;Hamers;Lancet Infect Dis,2012
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Major Drug Resistance Mutations on Reverse Transcriptase Gene in Human Immunodeficiency Virus Type-1 in Indonesia: A Systematic Review;Current HIV/AIDS Reports;2024-01-20
2. Integrase inhibitors: current protagonists in antiretroviral therapy;Immunotherapy;2023-12
3. Long-term outcomes of highly experienced people with HIV undergoing salvage therapy with raltegravir;Medicine;2023-10-06
4. Field performance and cost‐effectiveness of a point‐of‐care triage test for HIV virological failure in Southern Africa;Journal of the International AIDS Society;2023-10
5. Diagnostic accuracy of a point‐of‐care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz‐based antiretroviral therapy;Journal of the International AIDS Society;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3